Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...

The company disclosed preliminary results in mid January, but it left out important metrics such as earnings per share for the fourth quarter.

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...